AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Milestone Scientific Achieves 25% Increase in Revenue for Q2 2025 with Strong International Dental Sales and 70% Gross Margin
ByAinvest
Thursday, Aug 14, 2025 4:15 pm ET1min read
Milestone Scientific reports a 25% increase in revenue to $2.3 million in Q2 2025, driven by strong international dental sales. The company has strengthened its leadership and governance, appointing Eric Hines as CEO and Jason Papes as SVP of Global Sales and Marketing. Milestone is focused on accelerating momentum in both dental and medical businesses, streamlining operations, and expanding growth channels.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet